SOIL News and Press, Global X Fertilizers/Potash ETF Global X Funds From 08/14/19

The broad market's sell-off notwithstanding, cannabis stocks are under pressure after Tilray reported Q2 results after the close yesterday. Revenues were up 371% to $45.9M, albeit from a low base. Investors appear to be reacting to its disclosure that the average price per gram sold droppe...

via Amanda Chicago Lewis at the WSJ More news on: ETFMG Alternative Harvest ETF, Global X Fertilizers/Potash ETF, AdvisorShares Vice ETF, Healthcare stocks news, Consumer stocks news, News on ETFs Read more ...

Even with returns of more than 30% in 2019, pot exchange-traded funds will start to fade as investors wake up to the realization that marijuana investing is boring, Daniel Straus, vice president of ETFs and financial products research at National Bank of Canada, tells Bloomberg News. Mor...

In the latest pie-in-sky forecast , Stifel says the global cannabis market could reach $200B in the next 10 years, up from ~$8B in 2018. More news on: Canopy Growth Corporation, Tilray, Inc., Aurora Cannabis Inc., Healthcare stocks news, Consumer stocks news, Stocks on the move, News on E...

Cannabis producer Canopy Growth ( CGC -2.8% ) slips on average volume. Shares have retreated almost  11%  since Friday when it released fiscal 2019 results (year ended 3/31/19). More news on: Canopy Growth Corporation, Tilray, Inc., Aurora Cannabis Inc., Healthcare stocks new...

Health Canada officials will hold a media briefing tomorrow, June 14, at 12:30 pm ET to discuss the next steps in the legalization and regulation of cannabis there. More news on: Tilray, Inc., Aurora Cannabis Inc., Cronos Group Inc., Healthcare stocks news, Consumer stocks news, News on ET...

A just-published study has contradicted the findings of an early one that implied a connection between the availability of legal marijuana and opioid overdose deaths. More news on: Tilray, Inc., Cronos Group Inc., Canopy Growth Corporation, Healthcare stocks news, Consumer stocks news, Sto...

The Financial Times reports that the Church of England has given its investment arm the green light to invest in medical marijuana, a reversal of previous policy. More news on: Tilray, Inc., Aurora Cannabis Inc., Canopy Growth Corporation, Healthcare stocks news, Consumer stocks news, Ne...

Cannabis producer Cronos Group (NASDAQ: CRON ) is up  9%  premarket on modest volume on the heels of an upgrade from Underperform to Buy with a $20 (from $13) price target at BofA/Merrill Lynch. More news on: Cronos Group Inc., Tilray, Inc., Canopy Growth Corporation, Healthcare ...

As the FDA's first public hearing on cannabidiol (CBD) kicks off, Commissioner Ned Sharpless remarked that the agency still is uncertain how safe it is for human consumption. More news on: ETFMG Alternative Harvest ETF, Global X Fertilizers/Potash ETF, AdvisorShares Vice ETF, Healthcar...